Epigenetic Regulation of Cancer in Response to Chemotherapy: A Comprehensive Overview

Volume 158 of the Advances in Cancer Research series, “Epigenetic Regulation of Cancer in Response to Chemotherapy,” offers a profound insight into the latest advances in the field. This book, authored by Joseph Landry, presents a collection of chapters that delve into timely topics related to cancer research and chemotherapy.

Key Topics Covered

The book covers a wide range of topics, including:

1. Epigenetically Programmed Resistance to Chemotherapy and Promotion of Immune Evasion in Cancer
2. A Role for the Epigenome in Cancer Cell Drug Tolerance
3. Histone Methylation and X Chromosomal Genes in Metastasis of Breast Cancer
4. Targeting Epigenetic Regulation Using Small Molecule Inhibitors
5. Histone Deacetylase Inhibitors as Sanguine Epigenetic Therapeutics against Pugnacious Lung Cancer
6. From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia)
7. Predictive Models of Chemoresistance Generated by Crunching the Public Drug Screen
8. Epigenomic and Genomic Profiling Datasets via Regression-, Machine Learning, and Knowledge-Based Methods
9. Probing on the Mechanisms of lncRNAs on Cancer Drug Resistance
10. Drug Tolerant Persister Cells in Cancer: Current Knowledge and Therapeutic Perspectives

Author Expertise

Joseph Landry, the author of this book, is a renowned expert in the field of cancer research. His work has significantly contributed to the understanding of epigenetic regulation in cancer cells and its response to chemotherapy.

Publication Details

“Epigenetic Regulation of Cancer in Response to Chemotherapy” is published by Elsevier Science and was released on March 27, 2023. The book is available in English and has an ISBN of 9780443194184 for the print version and 9780443194191 for the e-book version.